<svg xmlns="http://www.w3.org/2000/svg" width="608" height="202.5" viewBox="0 0 608 202.5"><text transform="translate(0 86)" fill="#787b7f" font-size="18" font-family="MuseoSans-300, Museo Sans" font-weight="300"><tspan x="0" y="17">Bimekizumab efficacy and safety in moderate to severe plaque psoriasis </tspan><tspan x="0" y="39">(BE READY): a multicentre, double-blind, placebo-controlled, </tspan><tspan x="0" y="61">randomised withdrawal phase 3 trial.</tspan><tspan x="0" y="89">Gordon KB, Foley P, Krueger JG, et al. Published in 2021.</tspan></text><g style="isolation:isolate"><rect width="64" height="64" fill="#f18070" opacity="0.75"/><text transform="translate(32 22)" fill="#001489" font-size="12" font-family="MuseoSans-900, Museo Sans" font-weight="900"><tspan x="-19.452" y="0">PHASE</tspan></text><text transform="translate(32 49)" fill="#001489" font-size="28" font-family="MuseoSans-900, Museo Sans" font-weight="900"><tspan x="-8.218" y="0">3</tspan></text></g><g transform="translate(508 12)"><rect width="100" height="45" rx="3" fill="#71c5e8"/><text transform="translate(37 28)" fill="#001489" font-size="16" font-family="MuseoSans-500, Museo Sans" font-weight="500"><tspan x="0" y="0">View</tspan></text><g transform="translate(8 10)"><rect width="24" height="24" rx="12" fill="none"/><path d="M7.823,9.712a.735.735,0,0,0,0,1.067h0a.8.8,0,0,0,1.106,0l4.785-4.613a.919.919,0,0,0,0-1.333L8.929.221a.8.8,0,0,0-1.106,0h0a.735.735,0,0,0,0,1.067L11.41,4.746H.782A.769.769,0,0,0,0,5.5H0a.769.769,0,0,0,.782.754H11.41Z" transform="translate(5 7)" fill="#001489"/></g></g><line x2="608" transform="translate(0 202)" fill="none" stroke="#ccc" stroke-width="1"/><text transform="translate(81 29)" fill="#666" font-size="18" font-family="MuseoSans-900, Museo Sans" font-weight="900"><tspan x="0" y="0">BIMZELX (bimekizumab-bkzx)</tspan></text><text transform="translate(81 52)" fill="#666" font-size="18" font-family="MuseoSans-500, Museo Sans" font-weight="500"><tspan x="0" y="0">Plaque Psoriasis</tspan></text></svg>